Lung Cancer Surgery Equipment Market Report Examines Leading Companies And Growth Opportunities

The lung cancer surgery equipment market is on track for notable expansion over the coming years, driven by advancements in technology and growing demand for precise, minimally invasive procedures. This sector is evolving rapidly as new innovations and investments continue to reshape how lung cancer surgeries are performed and managed.

Lung Cancer Surgery Equipment Market Size and Expected Growth
The market for lung cancer surgery equipment is projected to reach a valuation of $5.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4%. This impressive growth is fueled by the advancement of robotic-assisted and minimally invasive surgical instruments. Additionally, the integration of AI-powered imaging and monitoring systems is playing a crucial role. Increased funding toward research institutions and academic centers, wider adoption of enhanced recovery after surgery (ERAS) protocols, and the growth of specialized lung cancer treatment facilities are further contributing to market expansion. Key trends shaping this sector include the rise in minimally invasive lung surgeries, greater demand for sophisticated imaging and diagnostic tools, incorporation of patient monitoring devices with surgical equipment, enhanced focus on postoperative care, and the spread of robotic-assisted thoracic procedures.

Download a free sample of the lung cancer surgery equipment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Factors Encouraging Growth in the Lung Cancer Surgery Equipment Market
One of the primary forces behind market growth is the increasing preference for minimally invasive lung surgeries, which offer faster recovery times and reduced complications. This shift is prompting manufacturers and healthcare providers to invest more in developing and adopting cutting-edge surgical tools that support these advanced techniques.
Moreover, significant investments in research and development by medical technology companies and academic institutions are accelerating the refinement of surgical devices. These efforts improve precision, safety, and effectiveness, thereby broadening the application of lung cancer surgery equipment across various healthcare settings.

Key Market Players Contributing to Innovation and Expansion
Several leading corporations dominate the lung cancer surgery equipment market, including Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, and Ambu A S.
A notable development in 2024 was Germany-based Karl Storz SE & Co. KG's acquisition of US company Asensus Surgical Inc. This strategic move aims to strengthen Karl Storz's position in the surgical robotics marketplace by integrating Asensus Surgical's advanced robotic-assisted and digital surgical technologies, specifically designed for procedures like lung cancer surgery.

View the full lung cancer surgery equipment market report:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Shaping the Lung Cancer Surgery Equipment Sector
One of the most promising trends is the development of robotically assisted bronchoscopy devices, which enhance accuracy and safety during tumor localization and biopsy. These robotic systems improve access to lung nodules that are difficult to reach using traditional techniques, facilitating earlier and more precise diagnoses.
For example, in March 2025, Johnson & Johnson announced that its MONARCH QUEST system-a state-of-the-art robotic-assisted bronchoscopy platform-received U.S. FDA 510(k) clearance. This system, which builds on the MONARCH Platform, integrates with the GE HealthCare OEC 3D mobile CBCT Imaging System to provide real-time, intraprocedural 3D imaging. This combination significantly boosts targeting accuracy for lung nodules, especially those in challenging lung regions.

Detailed Segmentation Covered in the Lung Cancer Surgery Equipment Market
This market is analyzed based on several key segments:
1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment
2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
3) By Application: Diagnosis, Treatment, Aftercare and Rehabilitation
4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research and Academic Institutes

Further breakdown of product types includes:
- Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures
- Access Devices: Trocars, Catheters, Guidewires, Introducers
- Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices
- Electrosurgical Devices: Generators, Probes, Electrodes, Smoke Evacuation Systems
- Biopsy Devices: Needle Biopsy, Core Biopsy, Vacuum-Assisted Biopsy, Endoscopic Biopsy Devices
- Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

This comprehensive segmentation helps stakeholders understand the diverse range of products, surgical techniques, and applications driving the lung cancer surgery equipment market.

New analytical features added to our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.